Adjunctive Evenamide effective, safe for schizophrenia

Newron Pharmaceuticals recently revealed favorable phase 2a study findings for Evenamide, an oral sodium channel blocker, in individuals with schizophrenia. To evaluate tolerability, safety and effectiveness of Evenamide as an adjunctive treatment for …